receptors—with a significantly higher affinity than THC—it is strictly regulated and sold only for laboratory research purposes.
WIN 55,212-2 is a synthetic cannabinoid receptor agonist primarily used in preclinical research for studying pain, inflammation, and neuroprotection. Because it is a highly potent full agonist of both CB1cap C cap B sub 1 CB2cap C cap B sub 2 win 55212 2 buy
Studies have identified several potential therapeutic pathways for WIN 55,212-2 in animal models: 212-2 in animal models: